European Organisation For Research & Treatment Of Cancer
Follow-up in Gynecological Cancer Survivors
- Conditions
- Gynecologic Cancer
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2024-01-24
- Target Recruit Count
- 1100
- Registration Number
- NCT03515993
- Locations
- 🇩🇪
Universitaetsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Germany
🇬🇧East Kent Hospitals University NHS Foundation Trust - Queen Elizabeth The Queen Mother Hospita, Margate, Kent, United Kingdom
🇦🇹Medical University of Graz, Graz, Austria
Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Other: Radiation TherapyDrug: Luteinising Hormone Releasing Hormone analog agonist (LHRHa)Drug: Non-steroidal anti-androgen
Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence
- Conditions
- Gastric and Esophagogastric Junction Adenocarcinoma
- Interventions
- Other: chemotherapy
- First Posted Date
- 2018-02-23
- Last Posted Date
- 2024-01-05
- Target Recruit Count
- 197
- Registration Number
- NCT03443856
- Locations
- 🇨🇿
Masaryk Memorial Cancer Institute, Brno, Czechia
🇩🇪SLK-Kliniken Heilbronn, Heilbronn, Germany
🇮🇱Rabbin Medical Centre - Tel Aviv, Tel Aviv, Israel
Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer
- Conditions
- Inoperable œsophageal Cancer
- Interventions
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2023-02-21
- Target Recruit Count
- 8
- Registration Number
- NCT03437200
- Locations
- 🇪🇸
Institut Catala d'Oncologia - ICO Badalona - Hospital De Mataro, Barcelona, Spain
🇪🇸Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia), Barcelona, Spain
🇫🇷Institut Gustave Roussy, Villejuif, France
PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL)
- Conditions
- Mycosis Fungoides/Sezary SyndromeLymphoma, T-Cell, Cutaneous
- Interventions
- First Posted Date
- 2017-11-29
- Last Posted Date
- 2024-02-22
- Target Recruit Count
- 26
- Registration Number
- NCT03357224
- Locations
- 🇪🇸
Hospital Universitario 12 De Octubre, Madrid, Spain
🇨🇭UniversitaetsSpital Zurich - Division of Dermatology, Zürich, Switzerland
A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
- Conditions
- Newly Diagnosed Glioblastoma
- Interventions
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2024-07-12
- Target Recruit Count
- 749
- Registration Number
- NCT03345095
- Locations
- 🇺🇸
University of California, San Francisco, California, United States
🇨🇦Saint John Regional Hospital, Saint John, New Brunswick, Canada
🇨🇭University Hospital of Geneva, Geneva, Switzerland
Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC)
- Conditions
- Squamous Non-small Cell Lung CancerNon-Squamous Non-small Cell Lung Cancer
- Interventions
Imaging Biomarker in Cancer Drug Induced ILD
- Conditions
- Drug Induced Interstitial Lung Disease (DIILD) Cancer Patients
- Interventions
- Other: Clinical evaluationsOther: Thoracic CT
- First Posted Date
- 2017-09-27
- Last Posted Date
- 2017-09-29
- Target Recruit Count
- 70
- Registration Number
- NCT03294746
Pembrolizumab in Biliary Tract Cancer
- Conditions
- Biliary Tract CancerMetastatic CancerAdvanced CancerGallbladder Cancer
- Interventions
- First Posted Date
- 2017-08-24
- Last Posted Date
- 2023-11-03
- Target Recruit Count
- 50
- Registration Number
- NCT03260712
- Locations
- 🇬🇧
Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, United Kingdom
🇪🇸Hospital Universitario 12 De Octubre, Madrid, Spain
🇬🇧The Christie NHS Foundation Trust, Manchester, United Kingdom
Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib
- Conditions
- Unresectable Stage III MelanomaStage IV Melanoma
- Interventions
- First Posted Date
- 2017-08-01
- Last Posted Date
- 2024-05-29
- Target Recruit Count
- 271
- Registration Number
- NCT03235245
- Locations
- 🇩🇰
Odense University Hospital, Odense, Denmark
🇫🇮Tampere University Hospital, Tampere, Finland
🇫🇷CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre, Bordeaux, France